Guardant Health (GH) Free Cash Flow Growth (1y) (2018 - 2026)
Guardant Health (GH) Free Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.28% |
| 10 | Guardant Health | 21.59 Bn | 20.53 Bn | 219.03 Mn | -5.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.46% |
| Mar 31, 2026 | -6.04% |
| Dec 31, 2025 | 87.98% |
| Sep 30, 2025 | 17.18% |
| Jun 30, 2025 | 33.45% |
| Mar 31, 2025 | -80.42% |
| Dec 31, 2024 | -23.36% |
| Sep 30, 2024 | 31.07% |
| Jun 30, 2024 | 0.96% |
| Mar 31, 2024 | 54.86% |
| Dec 31, 2023 | 57.56% |
| Sep 30, 2023 | -14.24% |
| Jun 30, 2023 | 5.75% |
| Mar 31, 2023 | -60.68% |
| Dec 31, 2022 | -56.77% |
| Sep 30, 2022 | 6.80% |
| Jun 30, 2022 | -30.60% |
| Mar 31, 2022 | -98.32% |
| Dec 31, 2021 | -11.55% |
| Sep 30, 2021 | -1,215.96% |